Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection

被引:56
作者
Jang, Kee-Taek [4 ]
Hong, Seung-Mo [5 ]
Lee, Kyu Taek [6 ]
Lee, Jong Gyun [6 ]
Choi, Seoung Ho [7 ]
Heo, Jin Seok [7 ]
Choi, Dong Wook [7 ]
Choi, Dongil [1 ,2 ,3 ]
Lim, Jae Hoon [1 ,2 ,3 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Samsung Med Ctr, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Clin Res Ctr, Samsung Biomed Res Inst, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul 135710, South Korea
[5] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[6] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul 135710, South Korea
[7] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul 135710, South Korea
关键词
Clonorchis sinensis; Intraductal papillary neoplasm of bile duct;
D O I
10.1007/s00428-008-0682-x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Intraductal papillary neoplasm of bile duct (IPNB) is one of the precursor lesions of cholangiocarcinoma. Although hepatolithiasis has been extensively studied in its association with IPNBs, there had been no comprehensive study of IPNBs with Clonorchis sinensis infection. Twelve IPNBs were selected from 20 surgically resected cholangiocarcinomas, positive for C. sinensis tests (60%) and compared with eight IPNBs, selected from 51 resected cholangiocarcinomas, negative for C. sinensis tests (16%), by histologic and immunohistochemical studies of mucin core proteins and cytokeratin panels. The predominant immuno-phenotype of IPNB cases with Clonorchiasis was pancreatobiliary type (MUC1+/MUC2-/CDX2-; 9/12 cases), while that of IPNB cases with negative for C. sinensis was intestinal type (MUC1-/MUC2+/CDX2+; 6/8; p=0.04). The prevalence of IPNBs was higher when patients with cholangiocarcinoma had Clonorchiasis. IPNBs with Clonorchiasis tended to have a more pancreatobiliary phenotype, which suggests IPNBs with Clonorchiasis may have a different tumorigenesis pathway from IPNBs with other etiologies.
引用
收藏
页码:589 / 598
页数:10
相关论文
共 36 条
  • [11] Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma
    Higashi, M
    Yonezawa, S
    Ho, JJL
    Tanaka, S
    Irimura, T
    Kim, YS
    Sato, E
    [J]. HEPATOLOGY, 1999, 30 (06) : 1347 - 1355
  • [12] Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases
    Hoang, MP
    Murakata, LA
    Katabi, N
    Henson, DE
    Albores-Saavedra, J
    [J]. MODERN PATHOLOGY, 2002, 15 (12) : 1251 - 1258
  • [13] An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms
    Hruban, RH
    Takaori, K
    Klimstra, DS
    Adsay, NV
    Albores-Saavedra, J
    Biankin, AV
    Biankin, SA
    Compton, C
    Fukushima, N
    Furukawa, T
    Goggins, M
    Kato, Y
    Klöppel, G
    Longnecker, DS
    Lüttges, J
    Maitra, A
    Offerhaus, GJA
    Shimizu, M
    Yonezawa, S
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (08) : 977 - 987
  • [14] Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis
    Ishikawa, A
    Sasaki, M
    Ohira, S
    Ohta, T
    Oda, K
    Nimura, Y
    Chen, MF
    Jan, YY
    Yeh, TS
    Nakanuma, Y
    [J]. LABORATORY INVESTIGATION, 2004, 84 (05) : 629 - 638
  • [15] Ji Y, 2008, HISTOL HISTOPATHOL, V23, P41, DOI 10.14670/HH-23.41
  • [16] Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas
    Kim, HJ
    Kim, MH
    Lee, SK
    Yoo, KS
    Park, ET
    Lim, BC
    Park, HJ
    Myung, SJ
    See, DW
    Min, YI
    [J]. ENDOSCOPY, 2000, 32 (05) : 389 - 393
  • [17] Biliary papillary hyperplasia with clonorchiasis resembling cholangiocarcinoma
    Kim, KH
    Kim, CD
    Lee, HS
    Lee, SJ
    Jeen, YT
    Chun, HJ
    Song, CW
    Lee, SW
    Um, SH
    Choi, JH
    Ryu, HS
    Hyun, JH
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (02) : 514 - 517
  • [18] KIM Y, 1984, ARZNEIMITTELFORSCH, V34-2, P1121
  • [19] KIM YI, 1989, CANCER, V63, P1562, DOI 10.1002/1097-0142(19890415)63:8<1562::AID-CNCR2820630819>3.0.CO
  • [20] 2-8